SCHEMBL15920403

SCHEMBL15920403

N#Cc1csc2c1CCCC2

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BPTF Q12830 2/20 0.41
ALDH1A1 P00352 6/20 0.40
MAPT P10636 4/20 0.40
HSD17B10 Q99714 3/20 0.40
ALOX15 P16050 2/20 0.40
GAA P10253 1/20 0.40
MAPK1 P28482 1/20 0.40
HPGD P15428 6/20 0.39
LMNA P02545 1/20 0.38
GFER P55789 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
HTT P42858 3/20 0.37
TP53 P04637 3/20 0.37
NPSR1 Q6W5P4 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
SMN1; SMN2 Q16637 6/20 0.35
NPC1 O15118 4/20 0.34
RAB9A P51151 3/20 0.34
ADRA2A P08913 2/20 0.34
ADRA2B P18089 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18430366 0.98 ALDH1A1 (0.43) BPTFALDH1A1MAPTHSD17B10ALOX15
SCHEMBL21598835 0.78 HTR2A (0.42)
SCHEMBL21598840 0.77 PNMT (0.39)
SCHEMBL25364670 0.72
SCHEMBL15848407 0.72 PNMT (0.41) MEN1KMT2A
SCHEMBL13021599 0.70 HPGD (0.44) ALDH1A1MAPTGAAHPGDLMNA
SCHEMBL2039293 0.70 HPGD (0.42) ALDH1A1MAPTHSD17B10HPGDLMNA
SCHEMBL25365128 0.70 ADRA1A (0.34) ALDH1A1MAPTHSD17B10NPSR1SMN1; SMN2
Hydrochloric Acid SCHEMBL31564391 0.69 NR2E1 (0.33)
SCHEMBL23840301 0.68 HPGD (0.44) ALDH1A1MAPTGAAMAPK1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4441050-A1 ANNULATED 2-AMINO-3-CYANO THIOPHENES AND DERIVATIVES FOR THE TREATMENT OF CANCER Boehringer Ingelheim International GmbH (DE) 2024-10-09 EP disclosed
WO-2023099592-A1 ANNULATED 2-AMINO-3-CYANO THIOPHENES AND DERIVATIVES FOR THE TREATMENT OF CANCER BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2023-06-08 WO disclosed
US-10655091-B2 Thiophene azo dyes and laundry care compositions containing the same THE PROCTER & GAMBLE COMPANY (US) 2020-05-19 US disclosed
US-20190345415-A1 THIOPHENE AZO DYES AND LAUNDRY CARE COMPOSITIONS CONTAINING THE SAME PROCTER & GAMBLE (US) 2019-11-14 US disclosed
US-10435651-B2 Thiophene azo dyes and laundry care compositions containing the same THE PROCTER & GAMBLE COMPANY (US) 2019-10-08 US disclosed
US-10195186-B2 N-substituted-5-substituted phthalamic acids as sortilin inhibitors H. LUNDBECK A/S (DK) 2019-02-05 US disclosed
US-20180066215-A1 THIOPHENE AZO DYES AND LAUNDRY CARE COMPOSITIONS CONTAINING THE SAME PROCTER & GAMBLE (US) 2018-03-08 US disclosed
US-9752104-B2 Thiophene AZO carboxylate dyes and laundry care compositions containing the same THE PROCTER & GAMBLE COMPANY (US) 2017-09-05 US disclosed
US-20170239226-A1 N-Substituted-5-Substituted Phthalamic Acids as Sortilin Inhibitors H. LUNDBECK A/S (DK) 2017-08-24 US disclosed
US-9682967-B2 N-substituted-5-substituted phthalamic acids as sortilin inhibitors H. LUNDBECK A/S (DK) 2017-06-20 US disclosed
EP-2638142-B1 THIOPHENE AZO DYES AND LAUNDRY CARE COMPOSITIONS CONTAINING THE SAME PROCTER & GAMBLE (US) 2017-05-10 EP disclosed
US-9567465-B2 Thiophene azo carboxylate dyes and laundry care compositions containing the same MILLIKEN & COMPANY (US) 2017-02-14 US disclosed
US-9556337-B2 Thiophene azo dyes and laundry care compositions containing the same MILLIKEN & COMPANY (US) 2017-01-31 US disclosed
US-20150368231-A1 N-SUBSTITUTED-5-SUBSTITUTED PHTHALAMIC ACIDS AS SORTILIN INHIBITORS H. LUNDBECK A/S (DK) 2015-12-24 US disclosed
WO-2014114779-A1 N-SUBSTITUTED-5-SUBSTITUTED PHTHALAMIC ACIDS AS SORTILIN INHIBITORS H. LUNDBECK A/S (DK) 2014-07-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150368231-A1 N-SUBSTITUTED-5-SUBSTITUTED PHTHALAMIC ACIDS AS SORTILIN INHIBITORS SORT1, NRP1, SELPLG BPTF 2322/4885ALDH1A1 1062/4885MAPT 22/4885
US-10195186-B2 N-substituted-5-substituted phthalamic acids as sortilin inhibitors SORT1, NRP1, SELPLG BPTF 2336/4885ALDH1A1 1271/4885MAPT 27/4885
US-20170239226-A1 N-Substituted-5-Substituted Phthalamic Acids as Sortilin Inhibitors SORT1, NRP1, SELPLG BPTF 2336/4885ALDH1A1 1271/4885MAPT 27/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.